Avidity Biosciences
RNA
#1835
Rank
โ‚น969.59 B
Marketcap
โ‚น6,435
Share price
0.13%
Change (1 day)
106.04%
Change (1 year)

Avidity Biosciences (RNA) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚น191.72 Billion

According to Avidity Biosciences's latest financial reports the company's total assets are โ‚น191.72 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Avidity Biosciences - Total assets on balance sheet (from 2019 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚น134.16 B156.39%
2023-12-31โ‚น52.32 B-1.01%
2022-12-31โ‚น52.86 B66.1%
2021-12-31โ‚น31.82 B30.33%
2020-12-31โ‚น24.41 B253.36%
2019-12-31โ‚น6.91 B2381.95%
2018-12-31โ‚น0.27 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
PTC Therapeutics
PTCT
โ‚น237.50 B 23.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
โ‚น7.32 B-96.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚น313.83 B 63.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
โ‚น94.47 B-50.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
โ‚น30.87 B-83.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น18.751 T 9,680.25%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น7.407 T 3,763.74%๐Ÿ‡ฌ๐Ÿ‡ง UK